Abstract:While balanced reciprocal translocations are relatively common, they often remain clinically silent unless they lead to the disruption of functional genes. In this study, we present the case of a boy exhibiting developmental delay and mild intellectual disability. Initial karyotyping revealed a translocation t(5;6)(q13;q23) between chromosomes 5 and 6 with limited resolution. Optical genome mapping (OGM) enabled a more precise depiction of the breakpoint regions involved in the reciprocal translocation. While the breakpoint region on chromosome 6 did not encompass any known gene, OGM revealed the disruption of the RASGRF2 (Ras protein-specific guanine nucleotide releasing factor 2) gene on chromosome 5, implicating RASGRF2 as a potential candidate gene contributing to the observed developmental delay in the patient. Variations in RASGRF2 have so far not been reported in developmental delay, but research on the RASGRF2 gene underscores its significance in various aspects of neurodevelopment, including synaptic plasticity, signaling pathways, and behavioral responses. This study highlights the utility of OGM in identifying breakpoint regions, providing possible insights into the understanding of neurodevelopmental disorders. It also helps affected individuals in gaining more knowledge about potential causes of their conditions.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify the disrupted genes in a patient with developmental delay carrying a de novo balanced reciprocal translocation through Optical Genome Mapping (OGM) technology. Specifically, the researchers found that there was a balanced reciprocal translocation (t(5;6)(q13;q23)) between the patient's chromosome 5 and chromosome 6, and precisely determined the breakpoint region of this translocation through OGM technology, revealing that the RASGRF2 gene on chromosome 5 was disrupted. The RASGRF2 gene plays an important role in neural development, and its dysfunction may be related to the patient's developmental delay. ### Main problems: 1. **Identification of gene disruption**: Through OGM technology, more precisely identify the breakpoint of the RASGRF2 gene on the patient's chromosome 5, so as to confirm whether this gene is related to the patient's developmental delay. 2. **Understanding the function of RASGRF2**: Explore the role of the RASGRF2 gene in neural development and the impact of its disruption on the patient's phenotype. 3. **Improving diagnostic accuracy**: Demonstrate the advantages of OGM technology in identifying chromosome rearrangement breakpoints, especially for high - resolution analysis of balanced reciprocal translocations, which helps to better understand the molecular mechanisms of neurodevelopmental disorders. ### Background information: - **Balanced reciprocal translocation**: This type of translocation usually does not lead to an increase or decrease in genetic material, but may disrupt key genes or regulatory regions, thereby causing clinical symptoms. - **RASGRF2 gene**: Encodes a calcium - regulated guanine nucleotide exchange factor (GEF), activates GTPases such as Ras and Rac1, and participates in the MAP kinase (MAPK) pathway, having an important impact on key activities such as cell proliferation, differentiation, and apoptosis. - **OGM technology**: Provides a higher resolution than traditional karyotype analysis and can be accurate to the gene level, which is helpful for identifying the specific location of chromosome rearrangements. ### Research methods: - **Sample collection and processing**: Extract ultra - long - molecular - weight genomic DNA from the patient's blood and use Bionano Genomics' kits for labeling and analysis. - **OGM analysis**: Use Saphyr chips for electrophoretic linearization to generate high - resolution genomic maps and identify chromosome breakpoints. ### Results: - **OGM confirms translocation**: Confirmed the translocation between the patient's chromosome 5 and chromosome 6, and precisely located the breakpoint region from the traditional q13;q23 to q14;q24. - **RASGRF2 gene disruption**: Found that exons 10 - 12 of the RASGRF2 gene were located within the breakpoint region, indicating that this gene may be disrupted. ### Discussion: - **Function of the RASGRF2 gene**: RASGRF2 plays an important role in neural development and signal transduction, and its disruption may lead to developmental delay and other neurodevelopmental disorders. - **Advantages of OGM technology**: Compared with traditional karyotype analysis, OGM technology provides a higher resolution, which helps to more precisely identify the breakpoints of chromosome rearrangements, providing new ideas for diagnosis and treatment. ### Conclusion: This study successfully identified the disruption of the patient's RASGRF2 gene through OGM technology and emphasized the important role of RASGRF2 in neural development. These findings not only help to understand the patient's clinical phenotype, but also provide an important reference for future research.

Optical Genome Mapping Reveals Disruption of the RASGRF2 Gene in a Patient with Developmental Delay Carrying a De Novo Balanced Reciprocal Translocation

Detection of Cryptic Balanced Chromosomal Rearrangements Using High-Resolution Optical Genome Mapping

Identification of a Familial Complex Chromosomal Rearrangement by Optical Genome Mapping.

Optical genome mapping with genome sequencing identifies subtelomeric Xq28 deletion and inserted 7p22.3 duplication in a male with multisystem developmental disorder

Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32

Clinical and Cytogenetic Impact of Maternal Balanced Double Translocation: A Familial Case of 15q11.2 Microduplication and Microdeletion Syndromes with Genetic Counselling Implications

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

Detection of Chromosomal Breakpoints in Patients with Developmental Delay and Speech Disorders.

Reciprocal chromosome translocation t(3;4)(q27;q31.2) with deletion of 3q27 and reduced FBXW7 expression in a patient with developmental delay, hypotonia, and seizures

Deciphering complex rearrangements at the breakpoint of an apparently balanced reciprocal translocation t(4:18)(q31;q11.2)dn and at a cryptic deletion: Further evidence of TLL1 as a causative gene for atrial septal defect

20.1 DISSECTING THE FUNCTIONAL CONSEQUENCES OF RECIPROCAL GENOMIC DISORDERS

Long-read sequencing and optical genome mapping identify causative gene disruptions in noncoding sequence in two patients with neurologic disease and known chromosome abnormalities

Genetic and functional characterization of inherited complex chromosomal rearrangements in a family with multisystem anomalies

Chromosomal translocation resolves a diagnostic odyssey for familial Ruvalcaba syndrome

Optical Genome Mapping (OGM) Identifies Multiple Structural Variants in a Case With Atypical Phelan‐McDermid Syndrome

Variant discovery and breakpoint region prediction for studying the human 22q11.2 deletion using BAC clone and whole genome sequencing analysis

Intellectual disability due to monoallelic variant in GATAD2B and mosaicism in unaffected parent

Clinical and neurogenetic characterisation of autosomal recessive RBL2-associated progressive neurodevelopmental disorder

The Application of Optical Genome Mapping (OGM) in Severe Short Stature Caused by Duplication of 15q14q21.3

Re‐analysis of whole genome sequencing ends a diagnostic odyssey: Case report of an RNU4‐2 related neurodevelopmental disorder

Balanced Translocation Disrupting JAG1 Identified by Optical Genomic Mapping in Suspected Alagille Syndrome